Celldex Therapeutics, Inc. Share-based Payment Arrangement, Expense
Celldex Therapeutics, Inc. (CLDX) reported Share-based Payment Arrangement, Expense of $8.41 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-06
- Celldex Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $8.41M, a 8.52% decline year-over-year.
- Celldex Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $8.52M, a 8.51% decline year-over-year.
- Celldex Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $8.91M, a 8.91% decline year-over-year.
- Celldex Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $8.80M, a 8.51% decline year-over-year.
- Celldex Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2025 was $36.22M, a 5.77% increase from fiscal 2024.
- Celldex Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2024 was $34.24M, a 43.33% increase from fiscal 2023.
- Celldex Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2023 was $23.89M, a 53.03% increase from fiscal 2022.
- Celldex Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2022 was $15.61M, a 74.37% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $8.41M 10-Q · filed 2026-08-06 | $16.93M 10-Q · filed 2026-08-06 | $25.84M derived: sum of 3 quarters · filed 2026-08-06 | $34.64M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $8.52M 10-Q · filed 2026-05-07 | $17.43M derived: sum of 2 quarters · filed 2026-05-07 | $26.23M derived: sum of 3 quarters · filed 2026-05-07 | $35.42M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $8.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $17.71M derived: sum of 2 quarters · filed 2026-02-25 | $26.90M derived: sum of 3 quarters · filed 2026-08-06 | $36.22M 10-K · filed 2026-02-25 |
| 2025-09-30 | $8.80M 10-Q · filed 2025-11-10 | $17.99M derived: sum of 2 quarters · filed 2026-08-06 | $27.31M 10-Q · filed 2025-11-10 | $37.09M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $9.19M 10-Q · filed 2026-08-06 | $18.51M 10-Q · filed 2026-08-06 | $28.29M derived: sum of 3 quarters · filed 2026-08-06 | $37.91M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $9.32M 10-Q · filed 2026-05-07 | $19.10M derived: sum of 2 quarters · filed 2026-05-07 | $28.72M derived: sum of 3 quarters · filed 2026-05-07 | $36.36M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $9.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $19.40M derived: sum of 2 quarters · filed 2026-02-25 | $27.04M derived: sum of 3 quarters · filed 2026-02-25 | $34.24M 10-K · filed 2026-02-25 |
| 2024-09-30 | $9.62M 10-Q · filed 2025-11-10 | $17.26M derived: sum of 2 quarters · filed 2025-11-10 | $24.46M 10-Q · filed 2025-11-10 | $31.67M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $7.64M 10-Q · filed 2025-08-07 | $14.84M 10-Q · filed 2025-08-07 | $22.05M derived: sum of 3 quarters · filed 2026-02-25 | $29.18M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $7.20M 10-Q · filed 2025-05-08 | $14.41M derived: sum of 2 quarters · filed 2026-02-25 | $21.54M derived: sum of 3 quarters · filed 2026-02-25 | $26.75M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $7.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $14.33M derived: sum of 2 quarters · filed 2026-02-25 | $19.55M derived: sum of 3 quarters · filed 2026-02-25 | $23.89M 10-K · filed 2026-02-25 |
| 2023-09-30 | $7.12M 10-Q · filed 2024-11-06 | $12.34M derived: sum of 2 quarters · filed 2024-11-06 | $16.68M 10-Q · filed 2024-11-06 | $21.19M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $5.22M 10-Q · filed 2024-08-08 | $9.56M 10-Q · filed 2024-08-08 | $14.06M derived: sum of 3 quarters · filed 2025-02-27 | $18.56M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $4.34M 10-Q · filed 2024-05-06 | $8.85M derived: sum of 2 quarters · filed 2025-02-27 | $13.34M derived: sum of 3 quarters · filed 2025-02-27 | $16.80M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $4.51M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $9.00M derived: sum of 2 quarters · filed 2025-02-27 | $12.46M derived: sum of 3 quarters · filed 2025-02-27 | $15.61M 10-K · filed 2025-02-27 |
| 2022-09-30 | $4.50M 10-Q · filed 2023-11-02 | $7.95M derived: sum of 2 quarters · filed 2023-11-02 | $11.10M 10-Q · filed 2023-11-02 | $14.24M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-06-30 | $3.45M 10-Q · filed 2023-08-08 | $6.61M 10-Q · filed 2023-08-08 | $9.75M derived: sum of 3 quarters · filed 2024-02-26 | $12.78M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-03-31 | $3.15M 10-Q · filed 2023-05-04 | $6.29M derived: sum of 2 quarters · filed 2024-02-26 | $9.32M derived: sum of 3 quarters · filed 2024-02-26 | $10.83M derived: sum of 4 quarters · filed 2024-02-26 |
| 2021-12-31 | $3.14M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $6.17M derived: sum of 2 quarters · filed 2024-02-26 | $7.68M derived: sum of 3 quarters · filed 2024-02-26 | $8.95M 10-K · filed 2024-02-26 |
| 2021-09-30 | $3.03M 10-Q · filed 2022-11-09 | $4.54M derived: sum of 2 quarters · filed 2022-11-09 | $5.81M 10-Q · filed 2022-11-09 | $7.07M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $1.51M 10-Q · filed 2022-08-08 | $2.78M 10-Q · filed 2022-08-08 | $4.04M derived: sum of 3 quarters · filed 2023-02-28 | $5.29M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $1.27M 10-Q · filed 2022-05-05 | $2.53M derived: sum of 2 quarters · filed 2023-02-28 | $3.78M derived: sum of 3 quarters · filed 2023-02-28 | $4.50M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $2.51M derived: sum of 2 quarters · filed 2023-02-28 | $3.23M derived: sum of 3 quarters · filed 2023-02-28 | $3.92M 10-K · filed 2023-02-28 |
| 2020-09-30 | $1.25M 10-Q · filed 2021-11-09 | $1.97M derived: sum of 2 quarters · filed 2021-11-09 | $2.66M 10-Q · filed 2021-11-09 | $3.35M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $722.00K 10-Q · filed 2021-08-05 | $1.41M 10-Q · filed 2021-08-05 | $2.10M derived: sum of 3 quarters · filed 2022-02-28 | $2.80M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $687.00K 10-Q · filed 2021-05-06 | $1.37M derived: sum of 2 quarters · filed 2022-02-28 | $2.08M derived: sum of 3 quarters · filed 2022-02-28 | $3.54M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $687.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $1.39M derived: sum of 2 quarters · filed 2022-02-28 | $2.86M derived: sum of 3 quarters · filed 2022-02-28 | $4.55M 10-K · filed 2022-02-28 |
| 2019-09-30 | $707.00K 10-Q · filed 2020-11-05 | $2.17M derived: sum of 2 quarters · filed 2020-11-05 | $3.86M 10-Q · filed 2020-11-05 | $5.62M derived: sum of 4 quarters · filed 2021-03-29 |
| 2019-06-30 | $1.46M 10-Q · filed 2020-08-06 | $3.16M 10-Q · filed 2020-08-06 | $4.91M derived: sum of 3 quarters · filed 2021-03-29 | $6.70M derived: sum of 4 quarters · filed 2021-03-29 |
| 2019-03-31 | $1.69M 10-Q · filed 2020-05-06 | $3.44M derived: sum of 2 quarters · filed 2021-03-29 | $5.24M derived: sum of 3 quarters · filed 2021-03-29 | $7.29M derived: sum of 4 quarters · filed 2021-03-29 |
| 2018-12-31 | $1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $3.54M derived: sum of 2 quarters · filed 2021-03-29 | $5.59M derived: sum of 3 quarters · filed 2021-03-29 | $8.08M 10-K · filed 2021-03-29 |
| 2018-09-30 | $1.79M 10-Q · filed 2019-11-12 | $3.84M derived: sum of 2 quarters · filed 2019-11-12 | $6.33M 10-Q · filed 2019-11-12 | $8.91M derived: sum of 4 quarters · filed 2020-03-26 |
| 2018-06-30 | $2.05M 10-Q · filed 2019-08-07 | $4.54M 10-Q · filed 2019-08-07 | $7.12M derived: sum of 3 quarters · filed 2020-03-26 | $9.86M derived: sum of 4 quarters · filed 2020-03-26 |
| 2018-03-31 | $2.49M 10-Q · filed 2019-05-07 | $5.07M derived: sum of 2 quarters · filed 2020-03-26 | $7.81M derived: sum of 3 quarters · filed 2020-03-26 | $11.26M derived: sum of 4 quarters · filed 2020-03-26 |
| 2017-12-31 | $2.58M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $5.32M derived: sum of 2 quarters · filed 2020-03-26 | $8.77M derived: sum of 3 quarters · filed 2020-03-26 | $12.31M 10-K · filed 2020-03-26 |
| 2017-09-30 | $2.74M 10-Q · filed 2018-11-07 | $6.19M derived: sum of 2 quarters · filed 2018-11-07 | $9.73M 10-Q · filed 2018-11-07 | $13.34M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-06-30 | $3.45M 10-Q · filed 2018-08-08 | $6.99M 10-Q · filed 2018-08-08 | $10.60M derived: sum of 3 quarters · filed 2019-03-07 | $14.39M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-03-31 | $3.54M 10-Q · filed 2018-05-10 | $7.15M derived: sum of 2 quarters · filed 2019-03-07 | $10.94M derived: sum of 3 quarters · filed 2019-03-07 | $14.92M derived: sum of 4 quarters · filed 2019-03-07 |
| 2016-12-31 | $3.61M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $7.40M derived: sum of 2 quarters · filed 2019-03-07 | $11.38M derived: sum of 3 quarters · filed 2019-03-07 | $15.32M 10-K · filed 2019-03-07 |
| 2016-09-30 | $3.80M 10-Q · filed 2017-11-07 | $7.77M derived: sum of 2 quarters · filed 2017-11-07 | $11.71M 10-Q · filed 2017-11-07 | $15.81M derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-06-30 | $3.97M 10-Q · filed 2017-08-08 | $7.91M 10-Q · filed 2017-08-08 | $12.01M derived: sum of 3 quarters · filed 2018-03-07 | $15.88M derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-03-31 | $3.94M 10-Q · filed 2017-05-09 | $8.04M derived: sum of 2 quarters · filed 2018-03-07 | $11.90M derived: sum of 3 quarters · filed 2018-03-07 | $14.43M derived: sum of 4 quarters · filed 2018-03-07 |
| 2015-12-31 | $4.10M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | $7.96M derived: sum of 2 quarters · filed 2018-03-07 | $10.49M derived: sum of 3 quarters · filed 2018-03-07 | $12.77M 10-K · filed 2018-03-07 |
| 2015-09-30 | $3.87M 10-Q · filed 2016-11-07 | $6.39M derived: sum of 2 quarters · filed 2016-11-07 | $8.68M 10-Q · filed 2016-11-07 | $10.81M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-06-30 | $2.53M 10-Q · filed 2016-08-08 | $4.81M 10-Q · filed 2016-08-08 | $6.94M derived: sum of 3 quarters · filed 2017-03-14 | $8.90M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-03-31 | $2.28M 10-Q · filed 2016-05-05 | $4.41M derived: sum of 2 quarters · filed 2017-03-14 | $6.37M derived: sum of 3 quarters · filed 2017-03-14 | $7.88M derived: sum of 4 quarters · filed 2017-03-14 |
| 2014-12-31 | $2.13M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $4.09M derived: sum of 2 quarters · filed 2017-03-14 | $5.60M derived: sum of 3 quarters · filed 2017-03-14 | $6.85M 10-K · filed 2017-03-14 |
| 2014-09-30 | $1.96M 10-Q · filed 2015-11-05 | $3.47M derived: sum of 2 quarters · filed 2015-11-05 | $4.72M 10-Q · filed 2015-11-05 | $5.87M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | $1.51M 10-Q · filed 2015-08-10 | $2.76M 10-Q · filed 2015-08-10 | $3.91M derived: sum of 3 quarters · filed 2016-02-25 | $5.92M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | $1.25M 10-Q · filed 2015-04-29 | $2.40M derived: sum of 2 quarters · filed 2016-02-25 | $4.41M derived: sum of 3 quarters · filed 2016-02-25 | $5.09M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | $1.15M derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-02-25 | $3.16M derived: sum of 2 quarters · filed 2016-02-25 | $3.84M derived: sum of 3 quarters · filed 2016-02-25 | $4.55M 10-K/A · filed 2016-02-25 |
| 2013-09-30 | $2.02M 10-Q · filed 2014-11-05 | $2.69M derived: sum of 2 quarters · filed 2014-11-05 | $3.40M 10-Q · filed 2014-11-05 | $4.08M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-06-30 | $676.00K 10-Q · filed 2014-08-07 | $1.38M 10-Q · filed 2014-08-07 | $2.07M derived: sum of 3 quarters · filed 2015-02-24 | $2.59M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-03-31 | $708.00K 10-Q · filed 2014-05-01 | $1.39M derived: sum of 2 quarters · filed 2015-02-24 | $1.92M derived: sum of 3 quarters · filed 2015-02-24 | $2.37M derived: sum of 4 quarters · filed 2015-02-24 |
| 2012-12-31 | $684.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $1.21M derived: sum of 2 quarters · filed 2015-02-24 | $1.66M derived: sum of 3 quarters · filed 2015-02-24 | $2.30M 10-K · filed 2015-02-24 |
| 2012-09-30 | $525.00K 10-Q · filed 2013-11-08 | $973.00K derived: sum of 2 quarters · filed 2013-11-08 | $1.61M 10-Q · filed 2013-11-08 | $2.25M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-06-30 | $448.00K 10-Q · filed 2013-08-06 | $1.09M 10-Q · filed 2013-08-06 | $1.73M derived: sum of 3 quarters · filed 2014-03-03 | $2.30M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-03-31 | $641.00K 10-Q · filed 2013-05-03 | $1.28M derived: sum of 2 quarters · filed 2014-03-03 | $1.85M derived: sum of 3 quarters · filed 2014-03-03 | $2.40M derived: sum of 4 quarters · filed 2014-03-03 |
| 2011-12-31 | $639.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $1.21M derived: sum of 2 quarters · filed 2014-03-03 | $1.76M derived: sum of 3 quarters · filed 2014-03-03 | $2.34M 10-K · filed 2014-03-03 |
| 2011-09-30 | $570.00K 10-Q · filed 2012-11-02 | $1.12M derived: sum of 2 quarters · filed 2012-11-02 | $1.70M 10-Q · filed 2012-11-02 | |
| 2011-06-30 | $553.00K 10-Q · filed 2012-08-09 | $1.13M 10-Q · filed 2012-08-09 | ||
| 2010-12-31 | $2.80M 10-K · filed 2013-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |